Kaizen Agro (538833)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 0.90 means price ₹20.21 is below book value ₹22.47.
• Sales growth of 83.95% and profit growth of 427.78% show strong recent momentum.
• Piotroski F-Score 7/9 indicates improving financial health.
• Latest quarter is profitable: ₹20 Cr sales and ₹1 Cr net profit.
• Low PEG of 0.09 leaves room for upside if growth persists.

Concerns

• ROE of only 1.94% and ROCE 0.47% show very weak returns on capital employed.
• P/E of 22.17 is not cheap for such low-quality, cyclical construction earnings, and there is no dividend.
• Reported P/E and ROE are inconsistent, and promoter holding is N/A, raising governance/transparency doubts.
• Very high profit growth is from a small base; the latest quarter's ₹1 Cr profit on ₹20 Cr sales is a thin 5% margin.

AI Analysis

At ₹20.21, Kaizen Agro appears cheap: book value is ₹22.47 per share, so I'd be buying a civil construction company at 0.9 times net assets. But Benjamin Graham taught me to pay attention not just to the price of the asset, but to what it earns. Here ROE is only 1.94% and ROCE just 0.47%, meaning this book value is not generating attractive returns. The latest quarter's ₹20 Cr revenue produced only ₹1 Cr profit—a thin 5% margin. In construction, where contracts go to the lowest bidder and orders are lumpy, such returns leave little protection. The 83.95% sales growth and 427.78% profit growth sound impressive, but the base is small; one good order can create that optics. A 22.17 P/E is rich for this quality of earnings, and with zero dividend, I'd need the business to compound for years. The Piotroski F-Score of 7 does say fundamentals are improving, and a PEG of 0.09 suggests the market is pricing in continued growth, but I must be wary: the reported P/E and ROE don't even reconcile, and promoter holding isn't disclosed. That makes me dig deeper, not cheer. If this is a genuine turnaround in a cyclical sector, I'd want to see ROCE climbing toward at least cost of capital, and margins holding at higher revenue levels. A cheap balance sheet is a comfort, but a wonderful business only comes when management finds a way to earn high returns on those assets. I can't yet call this a wonderful business. It's a possible asset-backed turnaround, but not a compounder. I'd let the numbers prove themselves over several quarters.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer